Beijing, China

Xiangxiang Wu

This inventor holds 1 USPTO granted patent. Top assignee: National Institutes for Food and Drug Control. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiangxiang Wu. Retrieved from https://idiyas.com/inventor/xiangxiang-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiangxiang Wu in Pharmaceutical Science

Introduction

Xiangxiang Wu is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. His work focuses on enhancing the efficacy and delivery of important medications.

Latest Patents

Xiangxiang Wu holds a patent for a cocrystal of progesterone and its preparation method and use. This invention relates to a cocrystal formed by the active ingredient progesterone and a cocrystal former selected from isophthalic acid, 4-formylbenzeneboronic acid, and 3-nitrophthalic acid. The patent outlines a method for preparing this cocrystal, which is aimed at increasing the thickness of the endometrium, improving progesterone's solubility, and enhancing its permeation rate.

Career Highlights

Xiangxiang Wu is affiliated with the National Institutes for Food and Drug Control, where he applies his expertise in drug formulation and development. His work has been instrumental in advancing pharmaceutical research and improving drug delivery systems.

Collaborations

Xiangxiang Wu collaborates with several professionals in his field, including Lan He and Jing Xiong. These collaborations enhance the research and development efforts within the pharmaceutical sector.

Conclusion

Xiangxiang Wu's innovative work in the development of progesterone cocrystals showcases his commitment to improving pharmaceutical formulations. His contributions are vital for advancing drug efficacy and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…